Tags: Drug.

Benralizumab (INN) is a monoclonal antibody which is being developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).

ATC prefix
none
CAS number
1044511-01-4
FDA UNII code
71492GE1FX

Loading...

This page contains content from the copyrighted Wikipedia article "Benralizumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.